Adherence, Side Effects and Efficacy of Stavudine plus Lamivudine plus Nelfinavir in Treatment-experienced HIV-infected Patients
- 1 July 2000
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 41 (1), 50-54
- https://doi.org/10.1053/jinf.2000.0678
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug ReactionsAnnals of Internal Medicine, 1999
- Nelfinavir Mesylate: A Protease InhibitorAnnals of Pharmacotherapy, 1999
- Rethinking Nonadherence: Historical Perspectives on Triple-Drug Therapy for HIV DiseaseAnnals of Internal Medicine, 1998
- The Era of Adherence to HIV TherapyAnnals of Internal Medicine, 1998
- Adherence and Antiretroviral Therapy in Injection Drug UsersJAMA, 1998
- Potential factors affecting adherence with HIV therapyAIDS, 1997
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- Protease Inhibitors in the HomelessJAMA, 1997
- LamivudineDrugs, 1997
- StavudineDrugs, 1996